US Patent Issued to Massachusetts Institute of Technology on May 13 for "Targeted trans-splicing using CRISPR/Cas13" (Massachusetts Inventor)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,433, issued on May 13, was assigned to Massachusetts Institute of Technology (Cambridge, Mass.).

"Targeted trans-splicing using CRISPR/Cas13" was invented by Jacob Borrajo (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides compositions and methods of using these compositions to mediate a targeted trans-splicing event on a pre-mRNA in a cell."

The patent was filed on Aug. 15, 2023, under Application No. 18/449,850.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50...